PRESS RELEASE published on 05/06/2026 at 14:20, 6 months 16 days ago Thirty years of values: the Fair Play Menarini International Award announces its 2026 edition The Fair Play Menarini International Award celebrates 30 years of honoring athletes with strong ethical values alongside competitive excellence. The upcoming 2026 edition will recognize sporting legends and emerging talents Athletes 2026 Edition Sporting Ethics Fair Play Menarini International Award 30 Years
BRIEF published on 12/08/2025 at 19:50, 11 months 13 days ago Le groupe Menarini présente les données de phase 2 de l'élacestrant au SABCS 2025. Phase 2 Cancer Du Sein Groupe Menarini Elacestrant Méta-analyse
BRIEF published on 12/08/2025 at 19:50, 11 months 13 days ago Menarini Group Showcases Phase 2 Elacestrant Data at 2025 SABCS Phase 2 Breast Cancer Menarini Group Elacestrant Meta-analysis
PRESS RELEASE published on 12/08/2025 at 19:45, 11 months 13 days ago Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium Menarini Group presents updated Phase 2 combination data of Elacestrant in ER+, HER2- metastatic breast cancer patients at 2025 San Antonio Breast Cancer Symposium, showing promising progression-free survival benefits and safety profiles Progression-free Survival Metastatic Breast Cancer Menarini Group Elacestrant Phase 2 Combination Data
BRIEF published on 11/24/2025 at 16:35, 11 months 27 days ago Le groupe Menarini dévoile de nouvelles données sur ELZONRIS® lors d'un congrès d'hématologie Oncologie Menarini ELZONRIS BPDCN Hématologie
BRIEF published on 11/24/2025 at 16:35, 11 months 27 days ago Menarini Group Unveils New ELZONRIS® Data at Hematology Meeting Oncology Menarini ELZONRIS BPDCN Hematology
PRESS RELEASE published on 11/24/2025 at 16:30, 11 months 27 days ago Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition Menarini Group and Stemline Therapeutics to present new data on ELZONRIS at ASH Annual Meeting. Data includes triplet therapy results for BPDCN patients ASH Annual Meeting Menarini Group ELZONRIS BPDCN Stemline Therapeutics
BRIEF published on 11/24/2025 at 15:35, 11 months 27 days ago Les Volpi Rosse Menarini : Prêts pour la saison 2025-2026 Volpi Rosse Menarini Eurocup 3 Basket-ball En Fauteuil Roulant Groupe Menarini Inclusion Sportive
BRIEF published on 11/24/2025 at 15:35, 11 months 27 days ago The Volpi Rosse Menarini: Ready for the 2025-2026 Season Wheelchair Basketball Volpi Rosse Menarini Eurocup 3 Menarini Group Sports Inclusion
PRESS RELEASE published on 11/24/2025 at 15:30, 11 months 27 days ago The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season Italian wheelchair basketball team, sponsored by Menarini, presented the new roster for the 2025/2026 season, aiming for success in Serie A and Eurocup 3 Série A 2025/2026 Season Wheelchair Basketball Eurocup 3 Menarini
Published on 11/20/2026 at 14:50, 2 days ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 2 days 1 hour ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 days 1 hour ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 days 1 hour ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 15 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 16 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 17 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 18 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 20 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 20 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 21 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 21 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 20 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR